A notable increase in dog ownership around the world, developing veterinary healthcare infrastructure and rising treatment options for canine arthritis are the key factors for the growth of the global canine arthritis treatment market.
As per the findings of Future Market Insights, the global canine arthritis treatment market is projected to experience significant growth during the forecast period, due to increasing prevalence of obesity induced arthritis among dogs and rise in awareness about the companion animal health. Moreover, ease in the FDA approval for novel and innovative canine arthritis treatment drugs will create growth opportunities for the market players.
The global canine arthritis treatment market stands at a net worth of US$ 2.39 Bn in 2022. Worldwide demand for canine arthritis treatment medications is predicted to rise at a CAGR of 4.2% and attain a market valuation of US$ 3.05 Bn by 2028.
Request a report sample to gain comprehensive insights at
|Canine Arthritis Treatment Market Size (2022)||US$ 2.39 Bn|
|Sales Forecast (2028)||US$ 3.05 Bn|
|Global Market Growth Rate (2022 to 2028)||4.2% CAGR|
|Share of Top 5 Market Players||55%|
Key Takeaways from Canine Arthritis Treatment Market Study
- Non-steroidal anti-inflammatory medications are referred as a first choice of veterinarian for the treatment of inflammation and pain. These medications are known to have effects, for example, decreasing tingling, allergic reaction, swelling, and pain. Canines approved non-steroidal anti-inflammatory medications have demonstrated acceptable safety profile, which is in contrast to non-approved NSAIDs.
- Growth prospects of the canine arthritis market are relatively high in North America as compared to other regions, attributed to rise in the adoption rate of canines, increasing veterinary expenditure on their health, and greater awareness about the pet health.
- Market players remained focused on capitalizing on veterinary hospitals and clinics, as they provide an entire animal care and service support for better pet health.
- Oral formulations of major non-steroidal anti corticosteroids medications will continue to account for major share of the manufacturers’ bottom lines, in the view of increasing demand for their ease of administration and better animal compliance.
For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-3552
Robust Clinical Development Pipeline to Dictate Stakeholders’ Strategies
Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading players in the canine arthritis treatment market. These manufacturers continue to dominate the market landscape of canine arthritis treatment by ensuring product availability, collaborating with the local distributors, strengthening manufacturing facilities, and strategizing R&D for diversification of product portfolio.
What did Analysts Uncover during the Study?
A comprehensive view of the canine arthritis treatment market has led our analysts to conclude that, the market is growing at an impressive rate, with North America and Europe holding a large share of the global canine arthritis treatment market. Increase in the pet adoption rate in developed economies, increase in the disposable expense on the companion animals, and rise in awareness regarding pet health are anticipated to propel the market growth.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3552
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Juvenile Idiopathic Arthritis Diagnostics Market – Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is musculoskeletal pain.
Rheumatoid Arthritis Treatment Market – Rheumatoid arthritis is associated with autoimmune that causes inflammation in joints of the body further the disease affects the muscle, connective tissues, joints, fibrous tissue, and tendons.
Psoriatic Arthritis (PsA) Treatment Market – Sales in the global Psoriatic Arthritis (PsA) Treatment Market are slated to top US$ 10.3 Bn in 2022. Expanding at a healthy 7.1% CAGR, the market size is projected to total US$ 15.6 Bn by 2028.
Reactive Arthritis Treatment Market – Reactive arthritis treatment market is growing due to the increasing prevalence of reactive arthritis diseases across the globe. Moreover, few indication also shows that people who smokes often are at high risk of developing reactive arthritis.
Osteoarthritis Gene Therapy Market – According to the latest research by Future Market Insights, the osteoarthritis gene therapy market is expected to grow at a CAGR of 8.7%. The demand outlook is anticipated to develop steadfast during the forecast period.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org